Saha D - Search Results

1

Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer.

Saha D, Dang HX, Zhang M, Quigley DA, Feng FY, Maher CA. Saha D, et al. NPJ Genom Med. 2024 Feb 23;9(1):14. doi: 10.1038/s41525-024-00401-3. NPJ Genom Med. 2024. PMID: 38396008 Free PMC article.

2

Single-cell transcriptomics reveals long noncoding RNAs associated with tumor biology and the microenvironment in pancreatic cancer.

Dang HX, Saha D, Jayasinghe R, Zhao S, Coonrod E, Mudd J, Goedegebuure SP, Fields R, Ding L, Maher CA. Dang HX, et al. Among authors: saha d. NAR Cancer. 2023 Nov 22;5(4):zcad055. doi: 10.1093/narcan/zcad055. eCollection 2023 Dec. NAR Cancer. 2023. PMID: 38023733 Free PMC article.

3

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer.

Chauhan PS, Alahi I, Sinha S, Shiang AL, Mueller R, Webster J, Dang HX, Saha D, Greiner L, Yang B, Ni G, Ledet EM, Babbra RK, Feng W, Harris PK, Qaium F, Jaeger EB, Miller PJ, Caputo SA, Sartor O, Pachynski RK, Maher CA, Chaudhuri AA. Chauhan PS, et al. Among authors: saha d. medRxiv [Preprint]. 2023 Dec 1:2023.12.01.23299215. doi: 10.1101/2023.12.01.23299215. medRxiv. 2023. Update in: Clin Cancer Res. 2024 Aug 23. doi: 10.1158/1078-0432.CCR-24-1658 PMID: 38077092 Free PMC article. Updated. Preprint.

4

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer.

Chauhan PS, Alahi I, Sinha S, Ledet EM, Mueller R, Linford J, Shiang AL, Webster J, Greiner L, Yang B, Ni G, Dang HX, Saha D, Babbra RK, Feng W, Harris PK, Qaium F, Duose DY, Sanchez-Espitia A, Sherry AD, Jaeger EB, Miller PJ, Caputo SA, Orme JJ, Lucien F, Park SS, Tang C, Pachynski RK, Sartor O, Maher CA, Chaudhuri AA. Chauhan PS, et al. Among authors: saha d. Clin Cancer Res. 2024 Aug 23. doi: 10.1158/1078-0432.CCR-24-1658. Online ahead of print. Clin Cancer Res. 2024. PMID: 39177583

5

Bacteria use exogenous peptidoglycan as a danger signal to trigger biofilm formation.

Vaidya S, Saha D, Rode DKH, Torrens G, Hansen MF, Singh PK, Jelli E, Nosho K, Jeckel H, Göttig S, Cava F, Drescher K. Vaidya S, et al. Among authors: saha d. Nat Microbiol. 2025 Jan 3. doi: 10.1038/s41564-024-01886-5. Online ahead of print. Nat Microbiol. 2025. PMID: 39753671

6

Understanding the Interplay between oHSV and the Host Immune System: Implications for Therapeutic Oncolytic Virus Development.

Ayele K, Wakimoto H, Nauwynck HJ, Kaufman HL, Rabkin SD, Saha D. Ayele K, et al. Among authors: saha d. Mol Ther. 2024 Dec 30:S1525-0016(24)00854-2. doi: 10.1016/j.ymthe.2024.12.054. Online ahead of print. Mol Ther. 2024. PMID: 39741405 Review.

7

Mindin/spondin-2 regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis.

Kataria S, Rana I, Badarinath K, Zaarour RF, Kansagara G, Ahmed S, Rizvi A, Saha D, Dam B, Dutta A, Zirmire RK, Hajam EY, Kumar P, Gulyani A, Jamora C. Kataria S, et al. Among authors: saha d. JCI Insight. 2024 Dec 31:e173071. doi: 10.1172/jci.insight.173071. Online ahead of print. JCI Insight. 2024. PMID: 39739417 Free article.

8

On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal.

Bhattacharyya P, Sen S, Ghosh S, Dey D, Sengupta S, Karmakar S, Saha D, Kar A, Banerjee R. Bhattacharyya P, et al. Among authors: saha d. Indian J Med Res. 2024 Nov;160(5):439-447. doi: 10.25259/ijmr_2404_23. Indian J Med Res. 2024. PMID: 39737506 Free PMC article.

9

Understanding the PULSAR effect in combined radiotherapy and immunotherapy using transformer-based attention mechanisms.

Peng H, Moore C, Saha D, Jiang S, Timmerman R. Peng H, et al. Among authors: saha d. Front Oncol. 2024 Dec 2;14:1497351. doi: 10.3389/fonc.2024.1497351. eCollection 2024. Front Oncol. 2024. PMID: 39687891 Free PMC article.

10

Biomimetic Approach for Optimal Designing of the Shape and Controlled Release of Therapeutics from Tricompartmental Microcarriers for Managing Parkinson's Disease.

Gupta N, Saha D, Thakur V, Yadav SS, Jat S, Kumar P, Datusalia AK, Satapathy BK, Saha S. Gupta N, et al. Among authors: saha d. ACS Appl Bio Mater. 2024 Dec 11. doi: 10.1021/acsabm.4c01149. Online ahead of print. ACS Appl Bio Mater. 2024. PMID: 39661489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

901 results

Search Page

Filters